Melanoma Institute Australia

This study tested a new approach for people with basal cell carcinoma (a common skin cancer) in sensitive areas like the face. Patients took a daily pill called sonidegib for 12 weeks before surgery. The goal was to shrink the tumor so the surgery would be smaller, cause less sca…

This study tested a personalized approach for patients with advanced melanoma that had not responded to standard immunotherapy. Researchers analyzed the genetic makeup of each patient's tumor to find specific mutations. Patients were then given a targeted drug designed to attack …